Free Trial
NASDAQ:DVAX

Dynavax Technologies (DVAX) Stock Price, News & Analysis

Dynavax Technologies logo
$10.28 +0.12 (+1.18%)
Closing price 07/3/2025 03:20 PM Eastern
Extended Trading
$10.28 0.00 (0.00%)
As of 07/3/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Dynavax Technologies Stock (NASDAQ:DVAX)

Key Stats

Today's Range
$10.12
$10.31
50-Day Range
$9.40
$11.75
52-Week Range
$9.22
$14.63
Volume
511,141 shs
Average Volume
2.17 million shs
Market Capitalization
$1.23 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$24.00
Consensus Rating
Moderate Buy

Company Overview

Dynavax Technologies Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
84th Percentile Overall Score

DVAX MarketRank™: 

Dynavax Technologies scored higher than 84% of companies evaluated by MarketBeat, and ranked 167th out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Dynavax Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on 3 buy ratings, no hold ratings, and 1 sell rating.

  • Amount of Analyst Coverage

    Dynavax Technologies has only been the subject of 2 research reports in the past 90 days.

  • Read more about Dynavax Technologies' stock forecast and price target.
  • Earnings Growth

    Earnings for Dynavax Technologies are expected to grow by 53.13% in the coming year, from $0.32 to $0.49 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Dynavax Technologies is -19.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Dynavax Technologies is -19.77, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Dynavax Technologies has a P/B Ratio of 2.26. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Dynavax Technologies' valuation and earnings.
  • Percentage of Shares Shorted

    13.26% of the float of Dynavax Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Dynavax Technologies has a short interest ratio ("days to cover") of 6.7.
  • Change versus previous month

    Short interest in Dynavax Technologies has recently decreased by 3.99%, indicating that investor sentiment is improving.
  • Dividend Yield

    Dynavax Technologies does not currently pay a dividend.

  • Dividend Growth

    Dynavax Technologies does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    13.26% of the float of Dynavax Technologies has been sold short.
  • Short Interest Ratio / Days to Cover

    Dynavax Technologies has a short interest ratio ("days to cover") of 6.7.
  • Change versus previous month

    Short interest in Dynavax Technologies has recently decreased by 3.99%, indicating that investor sentiment is improving.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Dynavax Technologies this week, compared to 5 articles on an average week.
  • Search Interest

    3 people have searched for DVAX on MarketBeat in the last 30 days. This is an increase of 200% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Dynavax Technologies insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.98% of the stock of Dynavax Technologies is held by insiders.

  • Percentage Held by Institutions

    96.96% of the stock of Dynavax Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Dynavax Technologies' insider trading history.
Receive DVAX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dynavax Technologies and its competitors with MarketBeat's FREE daily newsletter.

DVAX Stock News Headlines

DVAX - Dynavax Technologies Corp Key Metrics - Morningstar
DVAX Dynavax Technologies Corporation - Seeking Alpha
Gold buying hits 4-year high
The perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an epic bull rally in gold. JP Morgan and Goldman Sachs have a price target of $4,000. My research tells me gold could surpass $5,000 in the coming months. Folks using a very specific gold strategy since the 80s could have made more than 60 TIMES their money. Today, you can take advantage of a similar setup for around $10
See More Headlines

DVAX Stock Analysis - Frequently Asked Questions

Dynavax Technologies' stock was trading at $12.77 on January 1st, 2025. Since then, DVAX shares have decreased by 19.5% and is now trading at $10.28.

Dynavax Technologies Corporation (NASDAQ:DVAX) posted its quarterly earnings results on Tuesday, May, 6th. The biopharmaceutical company reported ($0.11) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.03 by $0.14. The biopharmaceutical company earned $68.16 million during the quarter, compared to analysts' expectations of $70.01 million. Dynavax Technologies had a negative net margin of 20.39% and a positive trailing twelve-month return on equity of 3.59%.
Read the conference call transcript
.

Shares of DVAX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dynavax Technologies investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), AU Optronics (AUOTY) and DiamondRock Hospitality (DRH).

Company Calendar

Last Earnings
5/06/2025
Today
7/05/2025
Next Earnings (Estimated)
8/05/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Biotechnology
Current Symbol
NASDAQ:DVAX
Employees
350
Year Founded
1996

Price Target and Rating

Average Stock Price Target
$24.00
High Stock Price Target
$31.00
Low Stock Price Target
$10.00
Potential Upside/Downside
+133.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
4 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
32.13
P/E Growth
N/A
Net Income
$27.31 million
Pretax Margin
-18.85%

Debt

Sales & Book Value

Annual Sales
$277.25 million
Cash Flow
$0.16 per share
Price / Cash Flow
64.86
Book Value
$4.54 per share
Price / Book
2.26

Miscellaneous

Free Float
116,503,000
Market Cap
$1.23 billion
Optionable
Optionable
Beta
1.03

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:DVAX) was last updated on 7/6/2025 by MarketBeat.com Staff
From Our Partners